Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method

JAMA Psychiatry

In this cross-sectional study, using the benchmark multiplier method and Medicaid administrative data in combination with data from the National Survey on Drug Use and Health for 2018 and 2019, the 12-month prevalence estimates of alcohol use disorder, cannabis use disorder, opioid use disorder, and stimulant use disorder were higher than estimates from the National Survey on Drug Use and Health. The findings suggest that the prevalence of substance use disorders may be considerably higher than National Survey on Drug Use and Health estimates indicate.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM